Clinical Trials
3 trialsNCT04197986 2024-03-13
PROOF302
QED Therapeutics, a BridgeBio company
Phase 3 Terminated
NCT02538471 2019-12-09
LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer
Weill Medical College of Cornell University
Phase 2 Terminated
NCT01893879 2017-05-18
PCTTPL
Stanford University
Phase NA Terminated